Topic
IPO Research
The current environment for IPOs is shaped by a resilient but narrow market rally, primarily driven by technology and software sector gains that set a high performance bar for new entrants. Research indicates a significant pipeline of potential candidates emerging from the massive AI buildout, where hyperscaler capital expenditure is projected to hit $1 trillion annually by 2028. While private equity and venture capital continue to attract interest due to historical outperformance, the rise of liquid vehicles tracking these segments has increased their correlation with public large-cap benchmarks. Institutional sentiment remains focused on quality fundamentals and U.S. large-cap core exposure, suggesting that upcoming offerings will face rigorous scrutiny regarding leverage and valuation metrics. Furthermore, expectations of stable Federal Reserve policy in the near term, followed by potential rate cuts as growth slows, may provide a stabilizing macro backdrop for valuation discovery. Ultimately, the research suggests that while market volatility remains a concern, the strategic shift toward active management and private market diversification is redefining the bridge between private funding and public equity listings.
4159 reports available
All reports
Page 162 of 174
Guide to US CPI Risks
Citi · May 11, 2026
Korea and Taiwan: How to Manage AI-Driven Super Surplus
Goldman Sachs · May 11, 2026
Resilient or Roaring 20s
UBS · May 11, 2026
Oscar Health 1Q26 Recap Hix Margin Comfort Affirmed Post Oep Growth Burst
Goldman Sachs · May 11, 2026
European Retail Virtual Roadshow Key Takeaways
Goldman Sachs · May 11, 2026
Sony Group CEO and CFO Meeting
Goldman Sachs Japan Co., Ltd. · May 11, 2026
Middle East Daily
MUFG · May 11, 2026
Introduce Bepirovirsen From GSK to Enrich Hepatitis Portfolio
Goldman Sachs · May 11, 2026
1Q New Guidance Above Expectations: AI Capex Benefits Are Broadening
Goldman Sachs · May 11, 2026
Shyam Metalics and Energy Q4FY26 Results Review
Goldman Sachs · May 11, 2026
Rockwool 1Q 2026 First Take
Goldman Sachs · May 11, 2026
Mosaic Q1 Results and Phosphate Production Curtailments
Goldman Sachs · May 11, 2026
Software Squeeze Potential and Positioning Analysis
The Market Ear · May 11, 2026
Philip Morris International: ZYN Ultra Rollout Following FDA Guidance
Goldman Sachs · May 11, 2026
MENA Chemicals: Recapping 1Q26 Trends and Updating Numbers
Goldman Sachs · May 11, 2026
State Litigation Reforms Support Sustained Insurer Margins
Goldman Sachs · May 11, 2026
Modi's Austerity Appeal and Risks of Prolonged Iran War
TS Lombard · May 11, 2026
Sentiment Buoyed by Hopes of a US-Iran Deal
Crédit Agricole CIB · May 11, 2026
Two Things to Watch in the Coming Week
UBS · May 11, 2026
Bath & Body Works Promotional Activity Update
Goldman Sachs · May 11, 2026
US Market Intelligence Morning Briefing
J.P. Morgan · May 11, 2026
Good Morning Mail
Goldman Sachs · May 11, 2026
Americas Small Cap Research Summary
Barclays · May 11, 2026
Evaluating Execution Risk for Avexitide Phase 3 Readout in Post-Bariatric Hypoglycemia
Goldman Sachs · May 11, 2026